A detailed history of Strs Ohio transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Strs Ohio holds 11,300 shares of RNA stock, worth $564,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,300
Previous 10,000 13.0%
Holding current value
$564,661
Previous $408,000 27.21%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$37.21 - $48.14 $48,373 - $62,582
1,300 Added 13.0%
11,300 $519,000
Q2 2024

Aug 05, 2024

BUY
$22.73 - $40.85 $227,300 - $408,500
10,000 New
10,000 $408,000
Q1 2021

Apr 23, 2021

SELL
$20.28 - $28.15 $85,176 - $118,230
-4,200 Closed
0 $0
Q3 2020

Dec 14, 2020

BUY
$23.35 - $35.94 $98,070 - $150,948
4,200 New
4,200 $118,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.6B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.